Christoph Wanner

Researcher Next ID · RN-001843

Researcher · Medicine

Würzburg, Germany

Not currently recruitingFunding unknown

Research interests

Medicine

Diabetes Treatment and Management

Dialysis and Renal Disease Management

Chronic Kidney Disease and Diabetes

Lysosomal Storage Disorders Research

Lipoproteins and Cardiovascular Health

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Journal of Hypertension · 2023 · https://doi.org/10.1097/hjh.0000000000003480
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab484
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2022190
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1515920
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504720

No projects listed.